Suvaxyn Parvo/E-Amphigen inj. emuls. i.m. vial
Country: Belgium
Language: English
Source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
Porcine Parvovirus ; Erysipelothrix rhusiopathiae (inactivated)
Available from:
Zoetis Belgium SA-NV
ATC code:
QI09AL01
INN (International Name):
Porcine Parvovirus; Erysipelothrix Rhusiopathiae, Inactivated
Pharmaceutical form:
Emulsion for injection
Composition:
Porcine Parvovirus; Erysipelothrix Rhusiopathiae, Inactivated
Administration route:
Intramuscular use
Therapeutic group:
pig
Therapeutic area:
Porcine Parvovirus + Erysipelothrix
Product summary:
CTI code: 506631-02 - Pack size: 25 doses (50 (50) - Commercialisation status: NO - FMD code: 05414736036175 - CNK code: 3631124 - Delivery mode: Medical prescription; CTI code: 506631-01 - Pack size: 10 doses (20 (20) - Commercialisation status: NO - Delivery mode: Medical prescription
Authorization status:
Commercialised: No
Authorization date:
2017-02-22
